Man, KKC, Coghill, D, Chan, EW, Lau, WCY, Hollis, C, Liddle, E, Banaschewski, T, McCarthy, S, Neubert, A, Sayal, K, et al.
Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system.
Translational Psychiatry
6(11)
:
e956 -e956
2016
view publication
Balia, C, Carucci, S, Donno, F, Coghill, D, Zuddas, A.
P.7.d.005 Do callous–unemotional traits modulate pharmacological treatment of aggression in children and adolescents with conduct disorder?.
European Neuropsychopharmacology
26:
s731
2016
view publication
Carucci, S, Romaniello, R, Lampis, A, Panei, P, Coghill, D, Zuddas, A.
P.7.d.006 Methylphenidate effects on height and bone age in ADHD children. 24 month follow up within the prospective ADDUCE project.
European Neuropsychopharmacology
26:
s731 -s732
2016
view publication
Romanos, M, Coghill, D, Gerlach, M, Becker, K, Holtmann, M, Döpfner, M, Banaschewski, T.
Check and Double Check - the Cochrane review by Storebo et al. (2015) is indeed flawed..
Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
44(5)
:
336 -337
2016
view publication
Kovshoff, H, Banaschewski, T, Buitelaar, JK, Carucci, S, Coghill, D, Danckaerts, M, Dittmann, RW, Falissard, B, Grimshaw, DG, Hollis, C, et al.
Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale.
Journal of Child and Adolescent Psychopharmacology
26(6)
:
537 -547
2016
view publication
